Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

Luteinizing Hormone Releasing Hormone (LHRH)

2 abstracts

Abstract
The effect of sodium glucose cotransporter-2 inhibitors on mortality and cardiovascular outcomes of patients with prostate cancer receiving luteinizing hormone releasing hormone agonists.
Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, Unity Hospital, Rochester Regional Health System, Rochester, NY, Mount Auburn Hospital,
Abstract
A window-of-opportunity (WOO) trial of giredestrant +/- LHRHa vs anastrozole+LHRHa in premenopausal women with ER+/HER2- early breast cancer (EBC; IBCSG 67-22; PREcoopERA).
Org: European Institute of Oncology, Milan, Italy, Dana-Farber Cancer Institute and International Breast Cancer Study Group Statistical Center, Boston, MA, Peter MacCallum Cancer Centre, Melbourne, Australia, European Institute of Oncology IRCCS, and University of Milan, Milano, Italy, Breast Unit, Helios University Clinic, University Witten-Herdecke, Wuppertal, Germany,